Bringing Israeli Medical Device Candidates To The Right Partners In The US

High Volume Of Medtech R&D Breakthroughs Is Due To Common Kinetic Elements That All Israeli Innovators Plug Into

Despite regional unrest, it is business as usual for medtech innovators and investors in Israel as evidenced by continued high-value M&A of locally developed technologies. Irit Yaniv, co-chair of the medtech session at the upcoming BioMed Israel 2025, explained the unique dynamics of Israeli medtech innovation.

Biomed Israel expects another full house in May 2025 (Alexander Elman)

More from Financing

More from Geography